Nascent Biotech, Inc. CEO Interviewed by The Wall Street Analyzer
05 févr. 2020 10h44 HE
|
Nascent Biotech, Inc.
San Diego, CA, Feb. 05, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nascent Biotech, Inc. (OTCQB: NBIO) is pleased to release a recent interview with company President | CEO Sean Carrick, on The...
Nascent Biotech Founder, Dr. Mark Glassy, Will Present at the Clinical Operation in Oncology Trials Meeting, in San Diego in February
30 janv. 2020 10h00 HE
|
Nascent Biotech, Inc.
SAN DIEGO, CA , Jan. 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nascent Biotech, Inc. (OTCQB: NBIO) founder Dr. Mark C. Glassy will be presenting on “Navigating the Unique Challenges Presented...
Nascent Biotech, Inc. Featured in New Research Update
15 janv. 2020 10h04 HE
|
Nascent Biotech, Inc.
San Diego, CA, Jan. 15, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nascent Biotech, Inc. (OTCQB: NBIO), an emerging biotech company, with IND Clearance and IRB approval to begin Clinical trials...
Nascent Biotech Receives One Million Dollar Commitment From TRITON FUNDS LP
11 sept. 2019 08h30 HE
|
Nascent Biotech, Inc.
SAN DIEGO, Calif., Sept. 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nascent Biotech, Inc. (OTCQB:NBIO), a biopharmaceutical company focusing on the development of monoclonal antibodies for the...
Nascent Biotech Has Entered into an Agreement to Perform Phase I Clinical Study for Brain Cancer
19 août 2019 14h04 HE
|
Nascent Biotech, Inc.
Study Planned for Multiple Brain Cancer Types in Phase I Setting San Diego, CA, Aug. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nascent Biotech, Inc. (OTCQB: NBIO), today announced they...
Nascent Biotech Officers Convert Liability to Stock in the Company
05 juin 2019 09h00 HE
|
Nascent Biotech, Inc.
San Diego, CA, June 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nascent Biotech, Inc. (OTC: NBIO) announced today that two of its Senior Officers have converted the Company’s liability to them...
Nascent Biotech Founder, Dr. Mark Glassy, Will Present at AAI Convention in San Diego
09 mai 2019 08h30 HE
|
Nascent Biotech, Inc.
SAN DIEGO, CA, May 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nascent Biotech, Inc. (OTCQB: NBIO) founder Dr. Mark C. Glassy will present an abstract on a natural human lgG1 mAb, Pritumumab,...
Nascent Biotech Moves Corporate Offices to San Diego
09 avr. 2019 12h53 HE
|
Nascent Biotech, Inc.
San Diego, CA, April 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nascent Biotech, Inc. (OTCQB: NBIO) has moved their corporate offices to San Diego, CA. Nascent CEO Sean Carrick stated,...
Nascent Biotech Receives Clearance From FDA to Begin Phase I Human Trials in Brain Cancer
11 déc. 2018 08h00 HE
|
Nascent Biotech, Inc.
Vero Beach, FL, Dec. 11, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nascent Biotech, Inc. (OTC: NBIO) received US Food and Drug Administration (FDA) Clearance to begin Phase 1 Clinical Trials...